UB Paderborn / Katalog / Suche / in CDI

The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance

Expert review of respiratory medicine, 2019-02, Vol.13 (2), p.139-152

2019

Link zum Volltext

Verfügbarkeit prüfen

Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States

The Journal of infectious diseases, 2017-11, Vol.216 (9), p.1053-1062

2017

Link zum Volltext

Verfügbarkeit prüfen

Socioeconomic Position and the Incidence, Severity, and Clinical Outcomes of Hospitalized Patients With Community-Acquired Pneumonia

Public health reports (1974), 2020-05, Vol.135 (3), p.364-371

2020

Link zum Volltext

Verfügbarkeit prüfen

Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia

International journal of infectious diseases, 2013-02, Vol.17 (2), p.e76-e83

2013

Link zum Volltext

Verfügbarkeit prüfen

Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study

The Lancet infectious diseases, 2011-03, Vol.11 (3), p.181-189

2011

Link zum Volltext

Verfügbarkeit prüfen

Thrombocytopenia and Thrombocytosis at Time of Hospitalization Predict Mortality in Patients With Community-Acquired Pneumonia

Chest, 2010-02, Vol.137 (2), p.416-420

2010

Link zum Volltext

Verfügbarkeit prüfen

SMART-COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community-Acquired Pneumonia

Clinical infectious diseases, 2008-08, Vol.47 (3), p.375-384

2008

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic Mechanisms Underlying HIV-Infection Induced Susceptibility of CD4+ T Cells to Enhanced Activation-Induced FasL Expression and Cell Death

Journal of acquired immune deficiency syndromes (1999), 2021-01, Vol.86 (1), p.128

2021

Link zum Volltext

Verfügbarkeit prüfen

Future Research Directions in Pneumonia. NHLBI Working Group Report

American journal of respiratory and critical care medicine, 2018-07, Vol.198 (2), p.256-263

2018

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Nephrotoxicity and Association With Vancomycin Use in Intensive Care Unit Patients With Pneumonia: Retrospective Analysis of the IMPACT-HAP Database

Clinical therapeutics, 2012, Vol.34 (1), p.149-157

2012

Link zum Volltext

Verfügbarkeit prüfen

Long-term Mortality in Hospitalized Patients With Community-Acquired Pneumonia

The American journal of the medical sciences, 2017-05, Vol.353 (5), p.421-421

2017

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of oseltamivir treatment on clinical failure in hospitalized patients with lower respiratory tract infection

BMC infectious diseases, 2021-10, Vol.21 (1), p.1-1106, Article 1106

2021

Link zum Volltext

Verfügbarkeit prüfen

Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: Results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study

Respiratory medicine, 2013-07, Vol.107 (7), p.1101-1111

2013

Link zum Volltext

Verfügbarkeit prüfen

A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years

BMC infectious diseases, 2020-06, Vol.20 (1), p.1-10, Article 426

2020

Link zum Volltext

Verfügbarkeit prüfen

Ruling Out Legionella in Community-acquired Pneumonia

The American journal of medicine, 2014-10, Vol.127 (10), p.1010.e11-1010.e19

2014

Link zum Volltext

Verfügbarkeit prüfen

The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: Results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study

Vaccine, 2014-04, Vol.32 (19), p.2198-2203

2014

Link zum Volltext

Verfügbarkeit prüfen

A Worldwide Perspective of Atypical Pathogens in Community-acquired Pneumonia

American journal of respiratory and critical care medicine, 2007-05, Vol.175 (10), p.1086-1093

2007

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis of Respiratory Syncytial Virus in Adults Substantially Increases When Adding Sputum, Saliva, and Serology Testing to Nasopharyngeal Swab RT–PCR

Infectious diseases and therapy, 2023-06, Vol.12 (6), p.1593-1603

2023

Link zum Volltext

Verfügbarkeit prüfen

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age

Human vaccines & immunotherapeutics, 2020-06, Vol.16 (6), p.1280-1291

2020

Link zum Volltext

Verfügbarkeit prüfen

What is the association of cardiovascular events with clinical failure in patients with community-acquired pneumonia?

Infectious disease clinics of North America, 2013-03, Vol.27 (1), p.205

2013

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of Pneumococcal Pneumonia in Louisville, Kentucky, and Its Estimated Burden of Disease in the United States

Microorganisms (Basel), 2023-11, Vol.11 (11), p.2813

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine

Human vaccines & immunotherapeutics, 2020-06, Vol.16 (6), p.1272-1279

2020

Link zum Volltext

Verfügbarkeit prüfen

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data

Infectious diseases and therapy, 2020-09, Vol.9 (3), p.625-639

2020

Link zum Volltext

Verfügbarkeit prüfen

Association Between Time to Clinical Stability and Outcomes After Discharge in Hospitalized Patients With Community-Acquired Pneumonia

Chest, 2011-08, Vol.140 (2), p.482-488

2011

Link zum Volltext

Verfügbarkeit prüfen

Infection prevention and control and the refugee population: Experiences from the University of Louisville Global Health Center

American journal of infection control, 2017-06, Vol.45 (6), p.673-676

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance

Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States

Socioeconomic Position and the Incidence, Severity, and Clinical Outcomes of Hospitalized Patients With Community-Acquired Pneumonia

Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia

Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study

Thrombocytopenia and Thrombocytosis at Time of Hospitalization Predict Mortality in Patients With Community-Acquired Pneumonia

SMART-COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community-Acquired Pneumonia

Epigenetic Mechanisms Underlying HIV-Infection Induced Susceptibility of CD4+ T Cells to Enhanced Activation-Induced FasL Expression and Cell Death

Future Research Directions in Pneumonia. NHLBI Working Group Report

Incidence of Nephrotoxicity and Association With Vancomycin Use in Intensive Care Unit Patients With Pneumonia: Retrospective Analysis of the IMPACT-HAP Database

Long-term Mortality in Hospitalized Patients With Community-Acquired Pneumonia

Effectiveness of oseltamivir treatment on clinical failure in hospitalized patients with lower respiratory tract infection

Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: Results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study

A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years

Ruling Out Legionella in Community-acquired Pneumonia

The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: Results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study

A Worldwide Perspective of Atypical Pathogens in Community-acquired Pneumonia

Diagnosis of Respiratory Syncytial Virus in Adults Substantially Increases When Adding Sputum, Saliva, and Serology Testing to Nasopharyngeal Swab RT–PCR

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age

What is the association of cardiovascular events with clinical failure in patients with community-acquired pneumonia?

Epidemiology of Pneumococcal Pneumonia in Louisville, Kentucky, and Its Estimated Burden of Disease in the United States

Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data

Association Between Time to Clinical Stability and Outcomes After Discharge in Hospitalized Patients With Community-Acquired Pneumonia

Infection prevention and control and the refugee population: Experiences from the University of Louisville Global Health Center

Suchergebnisse filtern